Literature DB >> 18252253

Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.

Ki-Hong Kim1, Jung-Hyun Shim, Eun-Hee Seo, Min-Chul Cho, Jung-Woo Kang, Soo-Hyun Kim, Dae-Yeul Yu, Eun-Young Song, Hee-Gu Lee, Jung-Hoon Sohn, JinMan Kim, Charles A Dinarello, Do-Young Yoon.   

Abstract

The members of the IL-1 family play important roles in the development and pathogenesis of autoimmune and inflammatory diseases. Especially, IL-1 and IL-18 belong to the IL-1 family because they share structural similarity and require caspase-1 for processing. Currently, IL-18 has been studied for its biological effects in the broad spectrum of Th1- or Th2- related autoimmune diseases. IL-18 also uses a similar signaling pathway as that of IL-1 family members. Taken together these results, IL-18-inducible genes might also contribute to autoimmune and inflammatory diseases. It has recently been reported that an inducer of TNF-alpha was identified as one of IL-18 inducible genes in IL-18 responsible cells and named as a new cytokine IL-32. We have produced novel monoclonal anti IL-32 antibodies in order to help study IL-32 function and to develop improved diagnosis of IL-32-expressing tumors. Several mAbs reactive to IL-32 isoforms were prepared and characterized by the epitope analysis and Western blotting performed using various deletion mutants and IL-32 isoforms (IL-32alpha, beta, gamma, and delta). In order to optimize the sandwich ELISA for IL-32, recombinant IL-32alpha was added, followed by the addition of a biotinylated mAb KU32-52 into the microtiter plate wells pre-coated with a mAb KU32-07 or mAb KU32-56. The bound mAb was probed with a streptavidin conjugated to HRP. The epitope analysis and Western blot analysis revealed that mAb KU32-07 could detect only IL-32alpha and KU32-52 was bound to all isoforms, whereas KU32-56 were reactive to IL-32 alpha, beta, delta isoforms but not gamma isoform. These sandwich ELISAs were highly specific and had a minimal detection limit of 80 pg/ml (mean+3 SD of zero calibrator) and measuring range of up to 3000 pg/ml. An ELISA using a coating mAb KU32-07 and a capturing biotinylated mAb KU32-52 had no cross-reaction with other cytokines such as IL-32beta, IL-32gamma, IL-32delta, hIL-1alpha , IL-1beta , hIL-2, hIL-6, hIL-8, hIL-10, hIL-18, and hTNF-alpha. Intra-assay coefficients of variation were 11 to 6% (n=16) and inter-assay coefficients were 10 to 5% (n=9). Another ELISA using a coating mAb KU32-56 and a capturing biotinylated mAb KU32-52 detected both IL-32alpha and IL-32beta isoforms but not gamma and delta isoforms and had no cross-reaction with other cytokines such as hIL-1alpha , IL-1beta , hIL-2, hIL-6, hIL-8, hIL-10, hIL-18, and hTNF-alpha. One mAb KU32-09 was shown to react strongly on immunohistochemistry. Our newly established mAbs, KU32-07, KU32-09, KU32-52, KU32-56, have different and useful properties for the detection of IL-32 by immunohistochemistry, ELISA, and Western blotting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252253     DOI: 10.1016/j.jim.2007.12.017

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  24 in total

1.  Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Authors:  Kun-Yi Lai; Ya-Ching Chou; Jiun-Han Lin; Yi Liu; Kai-Min Lin; Shin-Lian Doong; Mei-Ru Chen; Te-Huei Yeh; Sue-Jane Lin; Ching-Hwa Tsai
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.

Authors:  Sojung Lee; Jung-Hee Kim; Heejong Kim; Jeong Woo Kang; Soo-Hyun Kim; Young Yang; Jinman Kim; JongSup Park; SurNie Park; JinTae Hong; Do-Young Yoon
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

3.  Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus.

Authors:  Jin-Kyoung Kim; Eunjung Lee; Soyoung Shin; Ki-woong Jeong; Jee-Young Lee; Su-Young Bae; Soo-Hyun Kim; Juneyoung Lee; Seong Ryul Kim; Dong Gun Lee; Jae-Sam Hwang; Yangmee Kim
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

4.  Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.

Authors:  Kosuke Sakitani; Yoshihiro Hirata; Yoku Hayakawa; Takako Serizawa; Wachiko Nakata; Ryota Takahashi; Hiroto Kinoshita; Kei Sakamoto; Hayato Nakagawa; Masao Akanuma; Haruhiko Yoshida; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

5.  Monoclonal antibodies directed against the outer membrane protein of Bordetella avium.

Authors:  Guanhua Liu; Manfei Liang; Xuemei Zuo; Xue Zhao; Fanxia Guo; Shifa Yang; Ruiliang Zhu
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-08

6.  Interleukin-32 expression in the pancreas.

Authors:  Atsushi Nishida; Akira Andoh; Osamu Inatomi; Yoshihide Fujiyama
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

7.  Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.

Authors:  A Okamura; K Harada; M Nio; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

8.  Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.

Authors:  Jeong-Woo Kang; Yun Sun Park; Dong Hun Lee; Jung-Hee Kim; Man Sub Kim; Yesol Bak; Jintae Hong; Do-Young Yoon
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

9.  Molecular characterization of IL-32 in human endothelial cells.

Authors:  Hanako Kobayashi; P Charles Lin
Journal:  Cytokine       Date:  2009-04-11       Impact factor: 3.861

10.  Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).

Authors:  Yongkui Li; Jiajia Xie; Xiupeng Xu; Li Liu; Yushun Wan; Yingle Liu; Chengliang Zhu; Ying Zhu
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.